CBOE Global Markets, Inc. (CBOE) announced a profit for fourth quarter that decreased from the same period last year and missed the ...
Fourth Quarter and Full Year Highlights* Diluted EPS for the Quarter of $1.86, Down 6 percent; Diluted EPS for the Full Year ...
Infrastructure upgrades near completion in advance of expected miner deliveries205 MW Vega project advancing on track for Q2 ...
DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...
Plus inc. (NASDAQ: PLUS), a leading provider of technology and financing solutions, today announced financial results for the three months and nine months ended December 31, 2024.
The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...